Antitumor activity of ZD6474, a potent inhibitor of vascular endothelial growth factor signaling and epidermal growth factor, in the metastatic orthotopic brain tumor model

被引：0
作者：
Kong, Doo-Slk [1 ]
Jeon, Ji-Won [1 ]
Jeon, Hyun jung [1 ]
Nam, Do-Hyun [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg,Samsung Biomed Res Inst, Seoul, South Korea
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2007年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [31] Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib(IressaTM)and to the antiangiogenic agent ZD6474:Cytotoxic and biomolecular effects
    Amalia Azzariti
    Letizia Porcelli
    Grazia Maria Simone
    Angelo Paradiso
    World Journal of Gastroenterology, 2006, (32) : 5140 - 5147
  • [32] Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib (Iressa™) and to the antiangiogenic agent ZD6474:: Cytotoxic and biomolecular effects
    Azzariti, Amalia
    Porcelli, Letizia
    Xu, Jian-Ming
    Simone, Grazia Maria
    Paradiso, Angelo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (32) : 5140 - 5147
  • [33] Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer
    Baker, CH
    Solorzano, CC
    Fidler, IJ
    CANCER RESEARCH, 2002, 62 (07) : 1996 - 2003
  • [34] Schedule-dependent effects of ZD6474, a potent inhibitor of VEGF signaling, combined with radiotherapy in a lung tumor xenograft model.
    Williams, KJ
    Telfer, BA
    Stratford, IJ
    Wedge, SR
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6141S - 6141S
  • [35] Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer
    Winder, Thomas
    Lenz, Heinz-Josef
    GASTROENTEROLOGY, 2010, 138 (06) : 2163 - 2176
  • [36] Diversity in tumor territory of meningioma: Protein expression in vascular endothelial growth factor and epidermal growth factor
    Mehdipour, Parvin
    Javan, Firoozeh
    Faghih-Jouibari, Morteza
    Khaleghi, Mehdi
    IRANIAN JOURNAL OF NEUROLOGY, 2019, 18 (02) : 43 - 49
  • [37] Vascular endothelial growth factor (VEGF) signaling in tumor progression
    Roskoski, Robert, Jr.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 62 (03) : 179 - 213
  • [38] Increased local vascular endothelial growth factor expression associated with antitumor activity of proteasome inhibitor
    T. Stokłosa
    J. Goła¸b
    C. Wójcik
    P. Włodarski
    A. Jalili
    P. Januszko
    A. Giermasz
    G. M. Wilczyński
    E. Pleban
    M. Marczak
    S. Wilk
    M. Jakóbisiak
    Apoptosis, 2004, 9 : 193 - 204
  • [39] Increased local vascular endothelial growth factor expression associated with antitumor activity of proteasome inhibitor
    Stoklosa, T
    Golab, J
    Wójcik, C
    Wlodarski, P
    Jalili, A
    Januszko, P
    Giermasz, A
    Wilczynski, GM
    Pleban, E
    Marczak, M
    Wilk, S
    Jakóbisiak, M
    APOPTOSIS, 2004, 9 (02) : 193 - 204
  • [40] A novel bispecific diabody targeting both vascular endothelial growth factor receptor 2 and epidermal growth factor receptor for enhanced antitumor activity
    Xu, Menghuai
    Jin, Haizhen
    Chen, Zhiguo
    Xie, Wei
    Wang, Youfu
    Wang, Yang
    Wang, Min
    Zhang, Juan
    Acheampong, Desmond Omane
    BIOTECHNOLOGY PROGRESS, 2016, 32 (02) : 294 - 302
12345